Position in ACIU
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$14,429
-$891 QoQ
Shares Held
5,247
+7.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mirae Asset Global Investments Co., Ltd. holds $260,099,014 across 207 Biotechnology names. ACIU ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
188,064 | $83,978,097 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
84,608 | $65,371,524 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
40,926 | $21,423,530 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
56,391 | $18,658,089 | |
| 5 | INSM |
INSMED Inc
|
92,080 | $15,056,920 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
23,740 | $7,050,067 | |
| 7 | RPRX |
Royalty Pharma plc
|
146,024 | $7,004,771 | |
| 8 | INCY |
Incyte Corp
|
47,258 | $4,447,922 |
All Filings in ACIU
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,429 | 5,247 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $15,320 | 4,879 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $11,218 | 3,882 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $7,874 | 3,879 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $6,187 | 3,309 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $8,899 | 3,296 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $13,521 | 3,577 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $11,782 | 2,953 | Shares | Sole | 2024-07-30 | |
| 2021-06-30 | $9,365 | 1,181 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||